Table 1.
Mission Indradhanush (MI): April 2015 to July 2017 | Intensified Mission Indradhanush (IMI): October 2017 to January 2018 | |
---|---|---|
Objective | Fully immunise 90% of infants by 2020 | Fully immunise 90% of infants by 2018 |
Leadership | Central health minister and secretary of Health and Family Welfare, monitored under the proactive governance and timely implementation system | Prime minister, central health minister and cabinet secretary, monitored under the proactive governance and timely implementation system |
Implementation | Ministry of Health and Ministry of Women and Child Development | Ministry of Health with support from 12 non-health ministries, including Ministry of Women and Child Development |
Selection criteria | Districts with lowest coverage and state priority: lowest coverage (n=201), intermediate coverage (n=296), and other districts (n=31) | Districts and areas which continued to underperform after the first mission (<70% coverage) and >13 000 missed/partially immunised children |
Target areas | 528 districts across 35 states | 173 districts (including 52 districts from northeastern states) and 17 urban areas across 24 states |
Period | Four phases, each consisting of four monthly rounds, with each round lasting for 1 week | One phase with four monthly rounds, each round lasting for 1 week |
Programme approach | • Improved microplanning, monitoring, social mobilisation and strengthened vaccination systems (especially in areas with inadequate staff numbers) • All vaccines under routine immunisation offered for children aged ≤2 years and pregnant women |
MI approach plus: • Rigorous head counts (validated by supervisors) for tracking and updating due lists to identify children aged ≤2 years and pregnant women for vaccination • More intensive planning and monitoring in hard to reach urban areas • Involving non-health sectors to deal with social barriers and gaps in knowledge in communities—and to create a vaccination “movement” • Additional financial support based on need, and flexibility in use of the fund |